Many existing cohort studies designed to investigate health effects of environmental exposures also collect data on genetic markers. The Early Life Exposures in Mexico to Environmental Toxicants project, for instance, has been genotyping single nucleotide polymorphisms on candidate genes involved in mental and nutrient metabolism and also in potentially shared metabolic pathways with the environmental exposures. Given the longitudinal nature of these cohort studies, rich exposure and outcome data are available to address novel questions regarding geneenvironment interaction (G × E). Latent variable (LV) models have been effectively used for dimension reduction, helping with multiple testing and multicollinearity issues in the presence of correlated multivariate exposures and outcomes. In this paper, we first propose a modeling strategy, based on LV models, to examine the association between repeated outcome measures (e.g., child weight) and a set of correlated exposure biomarkers (e.g., prenatal lead exposure). We then construct novel tests for G × E effects within the LV framework to examine effect modification of outcome-exposure association by genetic factors (e.g., the hemochromatosis gene). We consider two scenarios: one allowing dependence of the LV models on genes and the other assuming independence between the LV models and genes. We combine the two sets of estimates by shrinkage estimation to trade off bias and efficiency in a data-adaptive way. Using simulations, we evaluate the properties of the shrinkage estimates, and in particular, we demonstrate the need for this data-adaptive shrinkage given repeated outcome measures, exposure measures possibly repeated and time-varying gene-environment association.
Introduction
Most common human diseases have a multifactorial etiology involving genetic factors (G) and environmental exposures (E). In recent years, many environmental cohort studies initially designed to study environmental health effects have begun to collect genetic information on study participants. One of the initial goals of the Early Life Exposure in Mexico to Environmental Toxicants (ELEMENT) project, for ing this time-dependent interaction when the gene-environment association structure can vary over time.
Previous work in adaptive shrinkage in longitudinal studies is limited.
We organize the rest of this paper as follows: in Section 2, we present the LV models for both a set of correlated exposures and the longitudinal outcome including gene-environment interactions. We also incorporate varying degrees of G-E and G-b heteroscedasticity into our modeling framework and present shrinkage estimation to adaptively compromise between the most parsimonious and most flexible models. In Section 3, we present a more general LV model where the exposures may vary over time. Analyses of the ELEMENT data (Section 4) and simulation studies (Section 5) bring out salient features of our modeling and G × E testing strategy. Section 6 briefly discusses the advantages and limitations of our methodology and indicates possibilities for further extensions.
Latent variable models for G × E studies with longitudinal outcome

Model formulation
Let Y ij denote the health outcome for subject i (i = 1, … , N) at time t ij ( j = 1, … , n i ). Let U i be an m × 1 vector of latent exposures underlying the observed exposure measurements E i (p × 1, p > m). In our motivating example, m = 1, p = 4, and U represent prenatal lead exposure as reflected by the four lead biomarkers collected in several tissues. In other applications, variables in E may represent metabolites of a parent compound U [30] , and one can propose more than one U (m > 1) if more than one family of exposure biomarkers are observed (e.g., mercury and polychlorinated biphenyls) [31] , or if exposures are observed repeatedly over time [32] . Genetic subgroups are denoted by a categorical variable G i . For brevity, we consider only binary G i : for example given multiple risk alleles, this may be zero for wild type and one for at least one variant. To deal with more categories (e.g., quantiles of a polygenic risk score [33] ), we can simply use multiple dummy variables. Our LV models contain two parts: the exposure model and the outcome model.
The exposure model consists of a measurement model relating the observed exposure measurements E i to the LVs U i
and an accompanying model with covariates V i (q × 1) that may be related to the LVs U i
Mean vectors and 1 are p × 1, whereas factor loadings matrices Λ and Λ 1 are p × m (see identifiability constraints in the succeeding text). Note that (1) allows the intercepts and factor loadings to differ by genetic subgroups. The error vector i has zero mean and covariance matrix Θ G (p × p) that may also depend on genetic subgroups. The hypotheses of Λ 1 = 0, 1 = 0, and Θ G = Θ could be tested using standard procedures [34, 35] , which may have low power, but we avoid this model selection step by shrinkage estimation (see Section 2.2 for details). Regression coefficients 0 and 1 are m × 1, and V is m × q. The error vector i has mean zero and covariance matrix Φ G (m × m). In (1) and (2), 1 , Λ 1 , and 1 characterize the G-E association. We present the exposure model with coefficients independent of time, which is usually the case when we have time-invariant exposures (e.g., prenatal lead exposures). We also propose an extension of this model to time-varying exposures in Section 3. The outcome model follows the latent growth curve modeling approach [20, 36, 37] . The longitudinal trajectory is modeled by
where B 0i is the subject-specific intercept (e.g., birth weight for subject i) and B ki is the subject-specific slope corresponding to a known functional predictor term f k (t) (e.g., t, t 2 or t −1 , k = X1, … , K), which captures nonlinearity in the trajectories, and between-subject variation in the growth curves. We can choose f k 's from a known set of parametric functions using model selection criteria (e.g., Bayesian information criteria) [37] , prior to incorporating genes and exposures into the model. We assume that ij 's are independently distributed with mean zero and variance 2 (under a balanced design, the variance can be allowed to vary over time if necessary). The latent outcomes B 0i and B ki explain the correlation between Y ij 's. We then associate B 0i or B 0i and B ki with U i and G i conditional on a set of baseline covariates/confounders Z i via the following models:
The random effects b 0i and b ki have a joint normal distribution with mean zero and variance D G , again allowed to vary across genetic subgroups. By plugging (4) and (5) into (3), one can see that parameter vectors G×U,0 and G×U,k characterize the G × E effects at baseline and subsequent time points, respectively. To model the latent outcomes B k in (5) as fixed effects, we constrain the variance of its corresponding b k to be zero; the variance of B 0 will generally not be zero given the correlations among the repeated outcome measures. Although in the general notation of (5), we have allowed all baseline covariates Z i to be associated with B ki ; in practice, this may have to be restricted by certain assumptions, either from the perspective of estimating a potentially large number of parameters Z,k or through a priori knowledge that may rule out the effect of certain covariates on B ki . Such constraints can be readily imposed by fixing subsets of Z,k to be zero. Finally, if time-varying covariates are available, they can be added directly to (3) as fixed effects. In summary, (1) and (2) denote the relationships among observed and latent exposures and their relationships to covariates, and (3)-(5) link observed outcomes to latent growth outcomes, and latent outcomes to latent exposures, genes, and covariates. The parameters in (1)-(5) and their meanings are listed in Table I .
Overall G × E model
Models (1)-(5) are presented as general models for G × E analysis, allowing for time-varying G × E effects. In practice, we might first explore whether there is an overall G × E effect marginalized over time, that is, to test H 0 : G×U,0 = 0 in (4) while forcing G×U,k in (5) to be zero. We refer to this model as the 'overall G × E model'. In reference to Figure 1 , the overall G × E model describes the structural relationship between G, U, and B 0 while removing the dashed line representing G × E × T effects.
G × E × T model
To examine whether the G×E effects vary over time, we can test H 0 : G×U,k = 0 for all k = 1, … , K in (5) . We call the model that estimates G×U,k the 'G × E × T model', which corresponds to the presence of the dashed line in Figure 1 . However, because f k 's are chosen principally to model the trajectory of the health outcome, they may not fully capture the true functional form of the temporal variation in G × E effects. To gain a better idea of this functional form, we may resort to prior literature or exploratory methods. For example, if the outcome is measured at several fixed time points (e.g., yearly weight) and sample size is adequate, we may model the G × E effect on the outcome at each distinct time point separately (i.e., time treated as dummy variables). We then plot the G×E coefficients against time in a meta-regression analysis to gauge a suitable functional form of time-varying interaction. We may need to include a function of time, not necessarily a subset of the f k 's, to be incorporated into (5) to better model the G × E × T effect. We use our data example to illustrate such exploratory strategies.
Identifiability
To make the LV models identifiable, we put standard constraints on the model parameters [22, 38] . For instance, typical constraints involve having factor loading matrices be prespecified as block diagonal, which means that a given observed exposure reflects only one LV, letting the first element of each nonzero block be one, and fixing the first element of the intercepts to be zero. These constraints fix the mean and scale of the LV, which are otherwise not identifiable. We apply these types of constraints to the measurement model (1) . Specifically, we constrain the first entries of each block of Λ 0 to be one and the corresponding entries of 0 to zero so that the mean and scale of the LVs in the reference genetic subgroup are identifiable. However, as G appears also in (2), more constraints are needed. We additionally fix the first entries of the corresponding blocks of Λ 1 to be zero such that the units of the LV are the same in both groups; this ensures identifiability of the variance of the LV among the genetic reference subgroup, (2) . Similarly, we constrain the corresponding entries of 1 to be zero such that the difference in means of the latent exposures between the genetic subgroups (i.e., 1 in (2)) is identifiable. For instance, in the context of prenatal lead exposure (Section 4), the factor loading corresponding to patella lead in Λ 0 is set to 1 and the difference in the factor loading for patella lead between the genetic subgroups, element in Λ 1 , corresponding to patella lead is zero so that the units of the LV are in the units of patella lead concentration (μgPb/g) in both groups. We also assume that the off-diagonal elements of Θ G are zero, reflecting conditional independence between E i 's given U i . Note that this conditional independence is not strictly required and can be relaxed given strong a priori knowledge (e.g., use of the same laboratory or other circumstances that may give rise to additional correlation among E i 's). If sample size is small, we can consider additional constraints to reduce the number of parameters to be estimated, for example, forcing the elements of Θ G to be identical across genetic subgroups, that is, Θ G=0 = Θ G=1 .
Likelihood and estimation
′ and be the vector of all model parameters. Assuming normality for all residuals, and integrating over the LV, the joint marginal distribution of the observed outcomes and exposures for subject i has a multivariate normal density
We apply the standard maximum likelihood estimation (MLE) to our LV models, using the R package lavaan by Rosseel (2012) (http://lavaan.org) [39] . The parameter estimates are obtained by maximizing l( ). Variances for parameters can be obtained by inverting the information matrix I( ) = −E( 2 l( )∕ ′ ). The codes for implementing the methods are available at http://www-personal.umich.edu/∼brisa/.
G-E dependence and G-b heteroscedasticity
Our LV models for exposures and longitudinal outcome are presented in a general way, allowing for full dependence on the genetic factors. To reduce the dimensionality of the parameter space, we may impose a certain degree of G-E independence as well as G-b homoscedasticity. These assumptions may hold for external exposures (air pollution and heavy metals) and a set of genes unrelated to the exposure but may not be so plausible for behavioral exposures/outcomes and genes in the same metabolic pathway. The assumption of G-E independence and G-b homoscedasticity can potentially boost the power of tests for interaction. However, the estimates of interaction may be seriously biased when the underlying assumption is violated [27, 40] . In our study, the mean and variance of the subject's birth weight and rate of weight gain, as well as the prenatal lead exposure, may not all be independent of genetic factors. The HFE gene shares a common metabolic pathway with lead exposure [41] and may potentially induce higher variance in the outcomes. The G-b heteroscedasticity has not been previously discussed in the literature, but we consider it possible, because groups defined by G could influence not only the outcome mean but also its variance, and furthermore, misspecifying outcome variance when latent predictors are in the model could lead to substantial bias in the regression coefficients [32] .
It is difficult to determine the plausibility of the G-E dependence and G-b heteroscedasticity based on current data. A convenient and automated way is to model varying degrees of dependence and use shrinkage to obtain an estimator that balances bias and efficiency. In our study, we will first build the model under the most restrictive assumption that all the parameters are homogeneous across genotypes. We use 'AI' to denote the assumption of G-E independence and G-b homoscedasticity
In the second step, we relax all the constraints and build the model under the assumption of complete G-E dependence and G-b heteroscedasticity, denoted as 'AD'. We consider the possibility that the variances of the latent outcomes also depend on gene, that is, all parameters may vary across genetic subgroups.
Clearly, the AD model has many more parameters than the AI model. The AI model may improve efficiency for interaction estimates but could introduce bias if the assumed independence constraints are incorrect. On the other hand, the problem with the AD model is that larger sample sizes are needed to have precise estimates of the parameters of interest. If the sample size is modest, we may put constraints on parameters like Θ G . After estimating AI and AD, it is not straightforward to assess relative model fits for these two models. For instance, a simple two-stage approach of first testing the plausibility of parameter constraints using current data and then proceeding with AI or AD will incur a high Type-I error rate, because the study is likely underpowered to detect significant differences across genetic subgroups for all parameters. Adaptive shrinkage of the robust AD estimators to efficient AI estimators appears to be an attractive alternative.
Shrinkage estimation
We use shrinkage estimation to combine MLE estimates under assumptions of AI and AD following Chen et al. [29] . Denoting the two estimators bŷA I and̂A D , we definê
as the shrinkage estimator (SK). The multivariate shrinkage (MV) weights are K MV =V(V +̂̂T ) −1 witĥ =̂A I −̂A D .V is the estimated asymptotic variance matrix of the estimated differencê. Note that (6) is only defined for common parameters in the two models, and K MV is an s × s matrix (s is the dimension of̂A I ). An alternative way to obtain shrinkage weights is to calculate them separately for each parameter so that we only need to deal with parameters of primary interest. This is called 'component-wise (CW)' shrinkage, whose weights (K CW ) depend only on the variance and bias related to that component, that is, [29] . Because the SK depends on two correlated estimatorŝA D and AI , its variance is approximated using the multivariate delta method [26, 29] . In a given data analysis, the variance can also be straightforwardly obtained via bootstrap.
To understand how the SK works, we need to carefully examine the weights. As we know,̂A D is unbiased but may not be efficient due to the large number of parameters in the model. This is particularly a problem if the sample size is modest.̂A I , on the other hand, is usually efficient but can be seriously biased if AI is violated. When the bias is large, the weight K CW l goes toward zero, and one would favor AD . Otherwise, one will favor the more efficient̂A I . This is a typical bias-variance tradeoff [28] . The CW shrinkage tends to have better efficiency than the MV shrinkage, because K MV uses the full matrix V and large sampling errors in the off-diagonals ofV outweighs the potential efficiency gain from MV shrinkage [29] . Sánchez et al. [26] has shown that in the cross-sectional setting, the MV shrinkage has larger mean squared error (MSE) despite smaller bias. Given the longitudinal setting in our study that leads to a much larger number of parameters and therefore larger uncertainty in the off-diagonal elements ofV, we use CW shrinkage in all our subsequent development.
Extension to time-varying exposures
In Section 2, we have considered only time-independent exposures. Here, we present the extension of our method to time-varying exposures while all other notations remain the same. For subject i at time t ij , let E ij denote a p × 1 vector of observed exposure measurements and U ij be an m × 1 vector of latent exposures. Then, models (1) and (2) can be rewritten as
and
Note that the regression coefficients unrelated to G are the same as those in (1) and (2) as we assume the relationship between the observed exposure measurements and the underlying latent exposures for the reference genetic subgroup (G = 0) is constant over time. Meanwhile, by allowing coefficients 1j , Λ 1j , and 1j related to G to vary over time, we incorporate the possibility of the time-varying G-E association, that is, varying effect of genetic factors on exposure biomarkers over time. With age, different exposures may be metabolized differently inducing such time-varying G-E association [18] . The error vectors ij and ij both have mean zero, and their variances can be either time-independent (Θ G and Φ G , respectively) as in (1) and (2) or time-varying (Θ G,j and Φ Gj , respectively) depending on the application context. However, with moderate sample size, we may have to build more parsimonious models. For example, we may
In this way, we are averaging the G-E association over time. Given time-varying exposures, the outcome model can be modified as
where B * 0i
Note that in contrast to (3)- (5), we separate the G and U terms from the functional terms involved in the temporal growth trajectory and allow separate regression coefficients corresponding to G and U terms to vary over time. We can also assume that G,j , U,j , and G×U,j follow some specific parametric function of time. For example, if we believe that there is a linear trend of G × E effect over time, we would model G×U,j to be a linear function of time. Notations of parameters of covariates and variance components remain unchanged.
Example: weight growth prenatal lead exposure and the HFE gene
We used pooled data from ELEMENT, including three sequentially enrolled longitudinal birth cohorts recruited between 1994 and 2005 at maternity hospitals serving low-income to moderate-income populations in Mexico City [1] . We focused our analysis on children's weight as the health outcome, which was measured longitudinally from birth to 48 months. Prenatal lead exposure is the main exposure of interest, which has been demonstrated to have deleterious effects on birth weight [42] and weight trajectories [1] . Prenatal lead exposure biomarkers were collected on the mother and child, including lead concentrations in umbilical cord blood and maternal blood at delivery, and maternal bone lead concentrations at two bone sites (patella and tibia) [1, 42] . Among these four biomarkers, patella lead concentration is viewed as a better indicator of cumulative fetal exposure for two reasons: (i) bone lead biomarkers are more indicative of cumulative fetal exposure during pregnancy because blood lead primarily reflects the last three months of exposure due to its relatively shorter half-life and (ii) patella is preferred over tibia bone lead concentration because trabecular bone, such as the patella bone, has a faster turnover compared with cortical bone (such as tibia), and thus more closely reflects exposure to the fetus during pregnancy [43] .
Two known SNPs, C282Y and H63D, on the HFE gene [41] were considered as effect modifiers of the lead-growth association. Because of sparsity of data, we applied dominant models for genetic susceptibility and created a single indicator variable: zero for wild type on both SNPs and one for at least one copy of either of the risk alleles. Although the HFE gene has been primarily linked with iron metabolism [41] , it has also been shown to modify lead absorption in an age-dependent fashion [8, 44] . As such, it is possible that the correlations among exposure biomarkers may differ between wild types and variants, implying that the exposure model coefficients may differ by genetic subgroup. The HFE gene has also been shown to have joint health effects with lead exposure [6, 44] .
To be included in this analysis, children must be genotyped, have weight measured at more than two time points, and have at least one of the four prenatal exposures biomarkers (N = 758). We focused our analysis on time points at birth and months 4, 12, 18, 24, 30, 36, and 48 when the cohorts had over 60% complete weight measurements. We followed Afeiche et al. [1] in choosing additional covariates based on biological relevance. Missing data on covariates was imputed five times [45] , and parameter estimates from each imputed dataset were combined by standard formulae [46] .
The procedure to conduct our analysis can be summarized into the following steps:
(1) We defined an LV for prenatal lead exposure using the four lead biomarkers (Figure 1 ). Because patella lead is a preferred biomarker of cumulative lead exposure during pregnancy as mentioned before, the mean and scale of the LV are set equal to those of patella lead using the identifiability constraints described in Section 2.1. (2) We modeled the weight growth trajectories by regressing weight on time in the linear mixed model adjusting for selected covariates. We did not consider the genetic factor or lead exposures at this stage. We incorporated functions of t, t 2 , and log(t) (hence, K = 3) in the model to capture the time trend of the mean weight trajectory, which have been typically used to model growth trajectories in children [37] . We further examined the model fit with residual plots. (3) We fit the overall G × E model to the data to examine the marginal G × E effect averaged over the whole study period. (4) Given the balanced design with respect to time (except for missed visits), we explored the G × E effect for each time point by treating time as dummy variables, denoted as the 'discrete time G × E model'. Specifically, for subject i with genetic category G i at time j (i = 1, … , 758 and j = 1, … , 8 in our example),
where G,j , U,j and G×U,j are regression coefficients for genetic factor G i latent exposure U i and the interaction term, respectively, and X ij and j are vectors of covariates (including intercept) and regression coefficients, respectively. The error vector e
, where Σ 8×8 was unstructured in our analysis, based on model fit. By plotting G×U,j against t j , we found that although the outcome model included multiple f k (t)'s (i.e., t, t 2 and log(t)), the G× U × T term could be described with a simple linear function of time h(t) = t, a subset of f k (t)'s. In other applications, it is possible that h(t) is completely different from f k (t)'s. (5) We fit the G × E × T model to the data by forcing the coefficients of G × U terms corresponding to t 2 and log(t) to be zero while retaining all other terms, including the G × U term for t, in (5).
Results from the ELEMENT analysis
The weight data at birth is complete while at other ages, the percent of missingness ranges from 12.5% to 36.7% (Supplemental Materials, Table S1 ). The weight increases over time but with decreasing rate, and the variance is increasing (Figure 2) . By applying the overall G × E model, we do not find a significant overall G × E effect (Table II) . However, there is a decreasing trend in G × E effect over time when fitting the discrete time G × E model and plottinĝG ×U against time (aforementioned step 3, Figure 3 ). The negativêG ×U indicates that carrying a variant for the HFE gene may exacerbate the deleterious effects of prenatal lead exposures on weight growth, particularly after one year from birth. The decreasing trend indicates that the degree of exacerbation may escalate over time. Comparing the results from the overall G × E model and discrete time G × E model, it is clear that if we ignore the time-varying component in the G × E effect, we would completely miss the G × E signal. Guided by the discrete time G × E model, we fitted the G × E × T model with linear T (Table II) . We found a statistically significant̂G ×U×T , indicating that the modification of lead-growth association by HFE status is age-dependent. The estimates and robust standard errors under AI are fairly similar to those under AD, likely implying weak G-E and G-b associations. The negative estimates indicate that, on average, the variants compared with wild types may suffer from even further reductions in weight gain in association with higher lead exposure (i.e., further impairment in growth). Via shrinkage estimation, the further reduction in weight gain associated with 10μgPb/g higher patella bone concentration is estimated to increase by 96.9 g every 6 months. In other words, comparing two children that only differ in HFE status, if their patella lead level were both to increase by 10μgPb/g, the one in the variant group would gain less weight than the one in the wild-type group, and their difference in weight gain would increase by 96.9 g every 6 months. Using appropriate linear combinations of̂G ×U and̂G ×U×T , we also calculated estimates for the G × E association at each age as shown in Figure 3 . Compared with the discrete time G × E model, the estimates from the G × E × T model are generally similar, while the standard errors are much smaller, resulting in improved power. This example illustrates the value of thinking about timedependent features in interaction patterns as opposed to an interaction term that is assumed to be constant over time.
Simulation studies
We carried out simulation studies to assess the bias, efficiency, MSE, power, and Type-I error properties of our methods. Specifically, we considered three settings of simulations where the true models are as follows: (i) the null model of no G × E effect at any time point; (ii) time-independent G × E effect; and (iii) time-varying G × E effect.
Simulations with time-invariant exposures
We used a sample size of N = 500 that is typical in environmental health studies. The genetic subgroup was generated as a binary variable with prevalence 0.3: zero for all wild types and one for having at least one variant. We simulated four exposure measurements, assuming that they measured one latent exposure. The latent exposure, under AD, was simulated from N(0, 1) for the wild type group and N(1, 2) for the variant group (i.e., 1 = 1, Φ = 1, and Φ 1 = 2 in (2)), while under AI, N(0, 1) for both groups. The latent outcomes were generated as random intercept and random slope for each subject (K = 1 and f (t) = t in (3)). The longitudinal outcomes were generated at five equally spaced time points (t = 0, …, 4).
Our parameters of interest are G×U , the baseline difference in exposure effect between genetic subgroups, and G×U×T , the difference in the G × E effect by unit increase of time. The true interaction parameters for the three settings were (i) G×U = G×U×T = 0; (ii) G×U = 2, G×U×T = 0; and (iii) G×U = 2, G×U×T = −1 with the G × U × T term assumed to be linear in T, respectively. For all three settings, we investigated the properties of our estimators when the underlying data generating mechanism was AI or AD. For setting 3, we further considered two scenarios: (i) data was simulated under G-E independence and G-b heteroscedasticity, denoted as 'APD1', to isolate the role of G-b heteroscedasticity alone in determining the operating characteristics of the methods and (ii) data were simulated under G-E partial dependence (only a subset of exposures interactive with genes) and G-b homoscedasticity, denoted as 'APD2'. Details regarding the choice of remaining parameters and how they varied across genetic subgroups can be found in the Supplemental Materials, Table S3 . For settings 1 and 2, we fitted the overall G × E model, and for setting 3, we also fitted the G × E × T model. We summarized the results based on 500 replicated datasets.
Simulation results
Table III presents the estimates from the overall G × E model for all three settings. When there is no interaction in the true model ( G×U = G×U×T = 0) and the data are generated under AI, all methods have acceptable biases and Type-I error rates. However, when the data are generated under AD, only the MLE assuming AD and the SK retain probability of rejection of a null hypothesis (P(R)) close to 0.05 at the nominal level of 0.05. As expected, MLE assuming AI has bias and inflated Type-I error in this scenario. When the overall G × E effect exists ( G×U = 2 and G×U×T = 0), all approaches have power of at least 0.75 except MLE assuming AI with data generated under AD. This loss of power is primarily due to severe bias in̂G ×U (−36.0%). In the first two settings, the SK performs very similar to the correct estimator, in terms of bias, MSE, and power (P(R)). For setting 3 ( G×U = 2 and G×U×T = −1) when the overall G × E model is misspecified, none of these approaches have adequate performance. Table IV presents the results from fitting the model with linear G × U × T term to the data generated in setting 3. Under data scenario AI or APD1, all approaches have satisfactory performance with the correct approach being the most unbiased and efficient. However, under data scenario AD or APD2, MLE assuming AI is seriously biased for both G×U and G×U×T . The similarities between scenarios AI and APD1 and between AD and APD2 indicate that G-E dependence may be more critical than G-b heteroscedasticity for determining the performances of our methods. For each of the four scenarios, the SK maintains very acceptable bias and efficiency
Simulations with time-varying exposures
We also conducted simulations assuming exposures are measured concurrently with the outcome, as postulated in (1a)-(2a). Again, we generated outcomes and exposures at five time points. We simulated Table III . Bias (or percent bias), MSE, and rejection probabilities (P(R)) for estimates of timeindependent G × E effect ( G×U ) with data simulated under AI or AD sample size N = 500, with 500 replicates. exposures for each time point separately and also incorporated time-varying G-E association in the true model: AI for time points 1 and 2 and AD for time points 3, 4, and 5 (details on parameter setting can be found in the Supplemental Materials, Table S3 ). We set G-b heteroscedasticity for all time points. We considered two situations where there was no G × E effect ( G×U = G×U×T = 0) or there was timevarying G × E effect ( G×U = 2 and G×U×T = −1). Then, we applied two types of AD models: one with time-varying G-E association (AD1) and the other with time-independent G-E association (AD2). We also calculated MLE assuming AI and used shrinkage estimation to combine AD1 with AI, denoted as SK1, as well as AD2 with AI, denoted as SK2. As a comparison benchmark, we analyzed the data with the correct G-E and G-b association (only possible in a simulation study where we know the truth).
Simulation results
Under the setting with no G × E effect, we find that all the methods have P(R) (Type-I error) close to 0.05 at the significance level of 0.05 (Table V) . However, MLE assuming AI, as a parsimonious method with the most restricted set of assumptions, leads to large bias for G×U×T . MLE assuming AD2 also has some bias due to misspecification of the G-E association. When there is time-varying G × E effect, we find different results for G×U and G×U×T . Despite some bias from MLE assuming AI, all other methods show satisfactory performance for G×U . In contrast, the power for G×U×T is lower (0.60-0.76). MLEs assuming AI and AD2 yield biased estimates, while MLE assuming AD1 has much less bias but also reduced power, likely due to the large number of parameters (124 for AD1 versus 83 for correct model). SK1 has relatively acceptable performance in bias and power, when compared with SK2 and the correct method, which indicates that when dealing with time-varying exposures with possible time-varying G-E association, we need to include the more flexible model as a component for shrinkage estimation in order to control bias.
Discussion
The current study, as an extension of the cross-sectional outcome work by Sánchez et al. [26] , has multiple strengths. It further shows the advantages of using LV models to reduce dimensionality of correlated exposure variables and longitudinal outcome. It limits the number of tests to be conducted and boosts power by using a single integrated model. It also has a cohesive interpretation if the existence of LV is natural, as is the case for blood and bone lead biomarkers in our example. Furthermore, it takes into account the possibility of mutual dependence between gene, exposures, and outcome. By using shrinkage estimation, we avoid testing each assumption separately and still obtain estimates that retain good operating characteristics. The most important contribution is to posit a framework that allows time-varying interaction and time-varying association. When the G-E dependence varies over time, a shrinkage factor that accounts for heterogeneity of the G-E association is needed.
Further extensions to accommodate semi-parametric or non-parametric smoothing terms instead of the highly parametric longitudinal model we have considered seem a natural continuation of our work. The normality assumption on the random effects and errors can also be relaxed to incorporate non-normal data. Moreover, the outcome can be multivariate longitudinal [47] , and one may add another layer of measurement models for the outcome at each time point.
It is also important to consider how to define genetic subgroups to meaningfully stratify on genetic risk for a given outcome-exposure association. For the methods presented, genetic strata need to be determined a priori, for example, through the quantiles of a combined risk index from a pathway or a gene region. In ELEMENT, a very interesting question is how to model the mother-child pair of genes together [6] . However, the limited sample size will always be an issue if one is trying to have multiple genetic subgroups. Whether an LV model can help reduce dimensionality of a correlated gene space is also something to be explored in future studies.
